[ad_1] The FTSE 250 is struggling for momentum again as conflict in the Middle East shakes investor nerves. But not all UK mid-cap shares are stuck in the mire. ITV (LSE:ITV) shares were last up strongly in end-of-week trading after…
[ad_1] “ Altimmune reported a net loss of $27. Divyansh_Kasana · March 5, 2026 Altimmune reported a net loss of $27.4 million, or $0.27 per share, for the fourth quarter of 2025, compared to a net loss of $23.2 million,…
[ad_1] During the first few minutes of trading today (6 March), the Endeavour Mining (LSE:EDV) share price was largely unchanged as investors reacted to the release of the West African gold miners results for the year ended 31 December 2025.…
[ad_1] Performance Review Income Statement: Revenue and Expenses Profitability Metrics The misalignment of revenue and expenses pushed JD.Com into negative territory across all major earnings indicators. EBITDA was reported at $-118 million, representing a steep 106.6% year-over-year drop. The operational…
[ad_1] Nvidia (NASDAQ:NVDA) might be one of the S&P 500âs top-performing stocks of the last five years. But at todayâs prices, it doesnât exactly look expensive. While the share price has faltered in 2026, the underlying business continues to storm…
[ad_1] Revenue and Sales Trends For the fourth quarter of fiscal 2025, Kroger reported: Total sales: $34.73 billion Identical sales (excluding fuel): modest growth, reflecting continued demand for grocery staples Digital sales: up about 20% year over year, driven by…
[ad_1] Judging by the readership numbers we Fool writers see, many investors are highly interested in Greggs (LSE: GRG) shares and their movements. Even so, apologies for the brutal pun in my headline, which I simply couldn’t resist! Alas, the…
[ad_1] Revenue Performance Profitability and Margins Operational Highlights Fleet expansion and strategic asset management remained central to the company’s operational execution. During the fourth quarter, Global Ship Lease announced the acquisition of three 8,600 TEU eco-upgraded containerships for an aggregate…
[ad_1] Financial Performance and Liquidity Operating Expenses Pipeline and Operational Developments The company advanced its Duchenne muscular dystrophy program, reporting that patients treated with the pivotal dose of RGX-202 demonstrated an average improvement of 7.4 points on the North Star…
[ad_1] Revenue: $142.2 million, up sequentially from $128.9 million in Q3 2025 but slightly below $143.1 million in Q4 2024. Net income: $3.2 million Diluted EPS (GAAP): $0.14, compared with $0.05 in Q3 2025. The quarter reflected improving activity levels…